Author

Susmita Ghosh

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-6591-9147Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

CLIFFORD C. STEPHANiD· 1 shared Fan Fan· 1 shared Lee M. EllisiD· 1 shared Rajat BhattacharyaiD· 1 shared Reid Trenton PowelliD· 1 shared Scott KopetziD· 1 shared Yong Sung ParkiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

CLIFFORD C. STEPHANORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer

Susmita Ghosh, Fan Fan, Reid Trenton Powell, Yong Sung Park, CLIFFORD C. STEPHAN, Scott Kopetz, Lee M. Ellis, Rajat Bhattacharya

This study identifies paclitaxel as a synergistic partner for trametinib in KRAS-mutated colorectal cancer, showing enhanced anti-tumor effects in vitro and in vivo.

Therapeutic Advances in Medical Oncology · Jan 1, 2024Peer-reviewedCancer Biology